MediPal Holdings Corporation

Symbol: 7459.T

JPX

2488.5

JPY

Market price today

  • 13.9739

    P/E Ratio

  • 0.6082

    PEG Ratio

  • 522.63B

    MRK Cap

  • 0.02%

    DIV Yield

MediPal Holdings Corporation (7459-T) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.07%

Operating Profit Margin

0.01%

Net Profit Margin

0.01%

Return on Assets

0.02%

Return on Equity

0.06%

Return on Capital Employed

0.06%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Distribution
CEO:Mr. Shuichi Watanabe
Full-time employees:12795
City:Tokyo
Address:2-7-15, Yaesu
IPO:2001-01-01
CIK:

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.

General Outlook

When we look at how much money they make before expenses, they keep 0.069% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.014%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.011%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.020% return, is a testament to MediPal Holdings Corporation's adeptness in optimizing resource deployment. MediPal Holdings Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.065%. Furthermore, the proficiency of MediPal Holdings Corporation in capital utilization is underscored by a remarkable 0.064% return on capital employed.

Stock Prices

MediPal Holdings Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $2508.5, while its low point bottomed out at $2452.5. This variance in figures offers investors a lucid insight into the roller-coaster ride that is MediPal Holdings Corporation's stock market.

Liquidity Ratios

Analyzing 7459.T liquidity ratios reveals its financial health of the firm. The current ratio of 119.83% gauges short-term asset coverage for liabilities. The quick ratio (92.82%) assesses immediate liquidity, while the cash ratio (19.36%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio119.83%
Quick Ratio92.82%
Cash Ratio19.36%

Profitability Ratios

7459.T profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 1.91% underscores its earnings before tax deductions. The effective tax rate stands at 28.59%, revealing its tax efficiency. The net income per EBT, 55.49%, and the EBT per EBIT, 137.93%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 1.39%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin1.91%
Effective Tax Rate28.59%
Net Income per EBT55.49%
EBT per EBIT137.93%
EBIT per Revenue1.39%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.20, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding93
Days of Inventory Outstanding23
Operating Cycle107.83
Days of Payables Outstanding115
Cash Conversion Cycle-7
Receivables Turnover4.31
Payables Turnover3.17
Inventory Turnover15.82
Fixed Asset Turnover12.87
Asset Turnover1.87

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 259.54, and free cash flow per share, 259.54, depict cash generation on a per-share basis. The cash per share value, 1018.15, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.02, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share259.54
Free Cash Flow per Share259.54
Cash per Share1018.15
Operating Cash Flow Sales Ratio0.02
Free Cash Flow to Operating Cash Flow Ratio1.00

Debt and Leverage Ratios

An interest coverage of 2432.80 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Interest Coverage2432.80
Company Equity Multiplier3.23

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 2.48%, indicates top-line expansion, while the gross profit growth, 1.49%, reveals profitability trends. EBIT growth, 17.07%, and operating income growth, 17.07%, offer insights into operational profitability progression.

cards.indicatorcards.value
Revenue Growth2.48%
Gross Profit Growth1.49%
EBIT Growth17.07%
Operating Income Growth17.07%
EPS Growth-12.47%
EPS Diluted Growth-12.42%
Weighted Average Shares Diluted Growth-0.06%
Operating Cash Flow Growth77.71%
Free Cash Flow Growth125.45%
10-Year Revenue Growth per Share26.49%
5-Year Revenue Growth per Share12.42%
3-Year Revenue Growth per Share9.84%
10-Year Operating CF Growth per Share7.08%
5-Year Operating CF Growth per Share3.52%
3-Year Operating CF Growth per Share2.04%
10-Year Net Income Growth per Share70.41%
5-Year Net Income Growth per Share-9.08%
3-Year Net Income Growth per Share-17.70%
10-Year Shareholders Equity Growth per Share77.27%
5-Year Shareholders Equity Growth per Share17.60%
3-Year Shareholders Equity Growth per Share13.35%
10-Year Dividend per Share Growth per Share130.74%
5-Year Dividend per Share Growth per Share31.25%
3-Year Dividend per Share Growth per Share16.31%
Receivables Growth1.16%
Inventory Growth2.37%
Asset Growth1.76%
Book Value per Share Growth1.39%
Debt Growth-1.64%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.90, and the price to book ratio, 0.90, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.15, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 9.47, and price to operating cash flows, 9.51, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.90
Price to Book Ratio0.90
Price to Sales Ratio0.15
Price Cash Flow Ratio9.51
Price Earnings to Growth Ratio0.61
Enterprise Value Multiple8.82
Price Fair Value0.90
Price to Operating Cash Flow Ratio9.51
Price to Free Cash Flows Ratio9.47
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of MediPal Holdings Corporation (7459.T) on the JPX in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 13.974 in 2024.

What is the ticker symbol of MediPal Holdings Corporation stock?

The ticker symbol of MediPal Holdings Corporation stock is 7459.T.

What is company IPO date?

IPO date of MediPal Holdings Corporation is 2001-01-01.

What is company current share price?

Current share price is 2488.500 JPY.

What is stock market cap today?

The market cap of stock today is 522627197495.000.

What is PEG ratio in 2024?

The current 0.608 is 0.608 in 2024.

What is the number of employees in 2024?

In 2024 the company has 12795.